312 related articles for article (PubMed ID: 21671598)
1. Preparation and characterization of amino-linked heterocyclic carbene palladium, gold, and silver complexes and their use as anticancer agents that act by triggering apoptotic cell death.
Wang CH; Shih WC; Chang HC; Kuo YY; Hung WC; Ong TG; Li WS
J Med Chem; 2011 Jul; 54(14):5245-9. PubMed ID: 21671598
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
3. Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes.
Ray S; Mohan R; Singh JK; Samantaray MK; Shaikh MM; Panda D; Ghosh P
J Am Chem Soc; 2007 Dec; 129(48):15042-53. PubMed ID: 17988129
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological studies of silver N-heterocyclic carbene complexes derived from 4,5-diarylimidazole.
Liu W; Bensdorf K; Hagenbach A; Abram U; Niu B; Mariappan A; Gust R
Eur J Med Chem; 2011 Dec; 46(12):5927-34. PubMed ID: 22019187
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF).
Eloy L; Jarrousse AS; Teyssot ML; Gautier A; Morel L; Jolivalt C; Cresteil T; Roland S
ChemMedChem; 2012 May; 7(5):805-14. PubMed ID: 22383263
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type.
Rubbiani R; Can S; Kitanovic I; Alborzinia H; Stefanopoulou M; Kokoschka M; Mönchgesang S; Sheldrick WS; Wölfl S; Ott I
J Med Chem; 2011 Dec; 54(24):8646-57. PubMed ID: 22039997
[TBL] [Abstract][Full Text] [Related]
7. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
8. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
10. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties and mechanisms of mitochondria-targeted Ag(I) and Au(I) complexes containing N-heterocyclic carbenes derived from cyclophanes.
Li Y; Liu GF; Tan CP; Ji LN; Mao ZW
Metallomics; 2014 Aug; 6(8):1460-8. PubMed ID: 24788133
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
[TBL] [Abstract][Full Text] [Related]
13. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
[TBL] [Abstract][Full Text] [Related]
14. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
15. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
[TBL] [Abstract][Full Text] [Related]
16. Metal-N-heterocyclic carbene complexes as anti-tumor agents.
Hu C; Li X; Wang W; Zhang R; Deng L
Curr Med Chem; 2014 Apr; 21(10):1220-30. PubMed ID: 24350852
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological assays on cancer cells of dinuclear gold complexes with novel functionalised di(N-heterocyclic carbene) ligands.
Baron M; Bellemin-Laponnaz S; Tubaro C; Basato M; Bogialli S; Dolmella A
J Inorg Biochem; 2014 Dec; 141():94-102. PubMed ID: 25226437
[TBL] [Abstract][Full Text] [Related]
18. N-heterocyclic carbenes (NHC) with 1,2,4-oxadiazole-substituents related to natural products: synthesis, structure and potential antitumor activity of some corresponding gold(I) and silver(I) complexes.
Maftei CV; Fodor E; Jones PG; Freytag M; Franz MH; Kelter G; Fiebig HH; Tamm M; Neda I
Eur J Med Chem; 2015 Aug; 101():431-41. PubMed ID: 26185007
[TBL] [Abstract][Full Text] [Related]
19. Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin reductase inhibitors and DNA intercalators.
Meyer A; Oehninger L; Geldmacher Y; Alborzinia H; Wölfl S; Sheldrick WS; Ott I
ChemMedChem; 2014 Aug; 9(8):1794-800. PubMed ID: 24803348
[TBL] [Abstract][Full Text] [Related]
20. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
Liu W; Gust R
Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
